Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-23 16:50 UTC+10:00
Section: General
Factuality Score: 90
Opinion Category: Neutral
Topics: Economy & Finance, Financial Markets, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Roche reported falling sales in the first three months of the year, as the strength of the Swiss franc and generic competition for some of its older drugs weighed on the drugmaker.
--------------------------------------------------------------------